KHAYAL TAMER I (Chief Commercial Officer) sold 4.9% of their position (1.08K shares) of TRANSMEDICS GROUP, INC. on the open market
Open‑market sale worth $86.7K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/10/2025ACC: 0000950170-25-004192
Officer· Chief Commercial Officer
Since May 2019
-1.08K
Net shares
Net seller
$86.7K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
1.08K acquired · 2.17K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+1.08K
Price / share
$13.28
Trade value
$14.38K
% of position
5.2%
1/7/2025
20.84K→21.93K
Common Stock
Direct
Shares
−1.08K
Price / share
$80.05
Trade value
$86.69K
% of position
4.9%
1/7/2025
21.93K→20.84K
Total
Net shares
+0.00
Net value
-$72.31K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/7/2025 | M · Option Exercise | +1.08K | $13.28 | $14.38K | 5.2% | 20.84K | 21.93K |
| Common Stock Direct | 1/7/2025 | S · Sale | −1.08K | $80.05 | $86.69K | 4.9% | 21.93K | 20.84K |
| Total | +0.00 | -$72.31K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
1.08K shares
Shares
−1.08K
Strike price
13.28
Held after
15.17K
Exercisable
—
1/7/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock1.08K shares | 1/7/2025 | M · Option Exercise | −1.08K | 13.28 | — | 15.17K |